deferoxamine has been researched along with Infectious Diseases in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 8.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| "To review the adverse effects and risks of deferoxamine for the treatment of iron poisoning." | 4.79 | Risks of parenteral deferoxamine for acute iron poisoning. ( Howland, MA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Williams, A | 1 |
| Meyer, D | 1 |
| Howland, MA | 1 |
2 reviews available for deferoxamine and Infectious Diseases
| Article | Year |
|---|---|
Desferrioxamine as immunomodulatory agent during microorganism infection.
Topics: Animals; Communicable Diseases; Cytokines; Deferoxamine; Humans; Immunologic Factors; Iron Chelating | 2009 |
Risks of parenteral deferoxamine for acute iron poisoning.
Topics: Administration, Oral; Antidotes; Communicable Diseases; Deferoxamine; Ear Diseases; Eye Diseases; Hu | 1996 |